Urinary dysfunction with detrusor hyperactivity in women with Parkinson's disease cannot be blamed as a factor of worsening motor performance;Disfunção urinária com hiperatividade detrusora não é fator de risco para progressão do desempenho motor em mulheres com doença de Parkinson

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 9 A, 2013, Pages 591-595

  Campos Sousa, Raimundo Nonato ^a   Quagliato, Elizabeth Maria Aparecida Barasnevicius ^b   Almeida, Kelson James ^a   de Castro, Inácio Augusto Dias ^a   Campelo, Viriato ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Detrusor hyperreflexia; Detrusor overactivity; Parkinson's disease; Urinary symptoms

Indexed keywords

AGED; ARTICLE; BRADYKINESIA; COHORT ANALYSIS; CONTROLLED STUDY; DETRUSOR HYPERACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOEHN AND YAHR SCALE; HUMAN; HYPERACTIVITY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MOTOR PERFORMANCE; OBSERVATIONAL STUDY; OVERACTIVE BLADDER; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDY; RIGIDITY; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; URINARY DYSFUNCTION; URODYNAMICS;

EID: 84885033232     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20130101     Document Type: Article

References (27)

1. Hawkes C. The prodromal phase of sporadic Parkinson's disease: does it exist and if so how long is it? Mov Disord 2008;23:1799-1807.
2. Schrag A, Dodel R, Spottke A, et al. Rate of clinical progression in Parkinson's disease. A prospective study. Mov Disord 2007;22: 938-945.
3. Magalhaes MVM, Mendes A, Silva T, et al. Disautonomy in idiopathic Parkinson's disease. Prevalence and natural history. Mov Disord 1998;13(Suppl 2):S273.
4. Verbaan D, Marinus J, Visser M, et al. Patient reported autonomic symptoms in Parkinson's disease. Neurology 2007;69:323-341.
5. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237: 197-204.
6. Poewe W. Clinical measures of progression in Parkinson's disease. Mov Disord 2009;24(Suppl):S671-S676.
7. Braak H, Müller CM, Rüb U, et al. Pathology associated with sporadic Parkinson's disease - where does it end? J Neural Transm 2006;70: 89-97.
8. Selikhova M, Williams DR, Kempster PA, et al. A clinic-pathological study of subtypes in Parkinson's disease. Brain 2009:132;2947-2957.
9. Winge K, Nielsen K. Bladder dysfunction in advanced Parkinson's disease. Neurourol Urodyn 2012;31:1279-1283.
10. Uchiyama T, Sakakibara R, Yamamoto T, et al. Urinary dysfunction in early and untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2011;82:1382-1386.
11. Araki I, Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the International Prostate Symptom Score. J Neurol Neurosurg Psychiatry 2000;68:429-433.
12. Sakakibara R, Uchiyama T, Yamanishi T, et al. Bladder and bowel dysfunction in Parkinson's disease. J Neural Transm 2008;115: 443-460.
13. Cardozo L, Robinson D. Special considerations in premenopausal and postmenopausal women with symptoms of overactive bladder. Urology 2002;60 (Suppl 1):S64-S71.
14. Abrams P, Cardozo L, Fall M, et al. The standardisation of t{stroke}erminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-178.
15. Palleschi G, Pastore A, Stocchi F, et al. Correlation between the overactive bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. Clin Neuropharmacol 2006;29:220-229.
16. Gomes CM, Arap S, Trigo-Rocha F. Voiding dysfunction and urodynamic abnormalities in elderly patients. Rev Hosp Clín Fac Med S. Paulo 2004;59:206-215.
17. Winge K, Friberg L, Werdelin L, et al. Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease. Eur J Neurol 2005;12: 842-850.
18. Defreitas G, Lemack G, Zimmern P, et al. Distinguishing neurogenic from non-neurogenic detrusor overactivity: A urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson's disease. Urology 2003;62:651-655.
19. Garnett S, Abrams P. The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder. J Urology 2003;169:843-848.
20. Gershanik OS. Clinical problems in late-stage Parkinson's disease. J Neurol 2010;257:S288-S291.
21. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
22. Diagnostic and Statistical Manual of Mental Disorders-4th edition; DSM-IV; American Psychiatric Association 2000.
23. VanRooden S, Colas F, Martinez-Martin P, et al. Clinical subtypes of Parkinson's disease. Mov Disords 2011;26:51-58.
24. Araki I, Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the International Prostate Symptom Score. J Neurol Neurosurg Psychiatry 2000;68:429-433.
25. Hashimoto K, Oyama T, Sugiyama T, et al. Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D(1) and D(2) receptors in rats. J Pharmacological Sci 2003;92:143-148.
26. Greffard S, Verny M, Bonnet A, et al. Motor score of the unified Parkinson disease rating scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 2006;63: 584-588.
27. Alves G, Wentzel-Larsen T, Aarsland D, et al. Progression of motor impairment and disability in Parkinson's disease a population-based study. Neurology 2005;65:1436-1441.